Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
JACC. Cardiovascular Imaging|December 19, 2021
Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility TrialJoseph B Muhlestein, Kirk U Knowlton, Viet T Le, et al.
American Heart Journal|April 21, 2009
Superior predictive ability for death of a basic metabolic profile risk scoreHeidi T May, Benjamin D Horne, Brianna S Ronnow, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 9, 2011
Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison populationJason M Lappé, Benjamin D Horne, Svati H Shah, et al.
Journal of Cardiovascular Electrophysiology|May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation proceduresT Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
European Journal of Heart Failure|August 14, 2010
The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpointsBenjamin D Horne, Heidi T May, Abdallah G Kfoury, et al.
Pageof 20